Invention: A compound which was similar in structure to another patented compound (Robins et

al. Note Compound XVI). The only difference being the former having an anti-inflammatory
property.

Patentable: Yes

Ratio: The evidence produced at the trial proves that the compounds claimed by the plaintiffs
possess some unobvious and unexpected beneficial properties not possessed by the
homologous compound disclosed in the prior art defense patents. In view of this, such claimed
compounds constitute a patentable invention.